Pascal Onge-St

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: June 13, 2023

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion.

Journal: Scientific reports

Published: March 09, 2023

Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.

Journal: British journal of cancer

Published: January 03, 2023

Integrating artificial intelligence in bedside care for covid-19 and future pandemics.

Journal: BMJ (Clinical research ed.)

Published: January 01, 2022

Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.

Journal: Pharmacogenomics

Published: September 10, 2021

Identification of new ETV6 modulators through a high-throughput functional screening.

Journal: iScience

Published: August 13, 2021

Corrigendum to "Identification of divergent placental profiles in clinically distinct pregnancy complications revealed by the transcriptome" [Placenta 154 (2024): 184-192 / PMID: 39042974].

Corrigendum to "Identification of divergent placental profiles in clinically distinct pregnancy complications revealed by the transcriptome" [Placenta 154 (2024): 184-192 / PMID: 39042974].

HLA-B*15:01 and HLA-DRB1*07:01 as novel markers of acute GVHD in pediatric HSCT.

HLA-B*15:01 and HLA-DRB1*07:01 as novel markers of acute GVHD in pediatric HSCT.

Molecular signatures associated with venous thromboembolism in children with acute lymphoblastic leukemia.

Molecular signatures associated with venous thromboembolism in children with acute lymphoblastic leukemia.

Identification of divergent placental profiles in clinically distinct pregnancy complications revealed by the transcriptome.

Identification of divergent placental profiles in clinically distinct pregnancy complications revealed by the transcriptome.

CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.

CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in TCF3::PBX1 ALL.

CODA: an open-source platform for federated analysis and machine learning on distributed healthcare data.

CODA: an open-source platform for federated analysis and machine learning on distributed healthcare data.

Genetic Factors and Long-term Treatment-Related Neurocognitive Deficits, Anxiety, and Depression in Childhood Leukemia Survivors: An Exome-Wide Association Study.

Genetic Factors and Long-term Treatment-Related Neurocognitive Deficits, Anxiety, and Depression in Childhood Leukemia Survivors: An Exome-Wide Association Study.

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion.

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion.

Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.

Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.

Integrating artificial intelligence in bedside care for covid-19 and future pandemics.

Integrating artificial intelligence in bedside care for covid-19 and future pandemics.

Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.

Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia.

Identification of new ETV6 modulators through a high-throughput functional screening.

Identification of new ETV6 modulators through a high-throughput functional screening.

HLA-B15:01 and HLA-DRB107:01 as novel markers of acute GVHD in pediatric HSCT.

HLA-B15:01 and HLA-DRB107:01 as novel markers of acute GVHD in pediatric HSCT.